Richard Herring, MD
Allergy & Immunology · Charlotte, NCNPI 1619177102
Payments from drug & device makers
Across 485 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Grifols USA, LLC$545
- Regeneron Healthcare Solutions, Inc.$532
- Pfizer$504
- CSL Behring$488
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 100 | $2,235 |
| GSK | 99 | $1,826 |
| Grifols USA, LLC | 39 | $545 |
| Regeneron Healthcare Solutions, Inc. | 20 | $532 |
| Pfizer | 34 | $504 |
| CSL Behring | 21 | $488 |
| Sanofi | 17 | $429 |
| Optinose US, Inc. | 27 | $411 |
| Novartis | 22 | $405 |
| Amgen(2 entities) | 13 | $395 |
| Kaleo, Inc. | 18 | $358 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $352 |
| Pharming Healthcare, Inc. | 5 | $244 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $224 |
| Genentech USA, Inc. | 10 | $154 |
| LEO Pharma Inc. | 2 | $147 |
| Regeneron | 1 | $144 |
| Incyte Corporation | 2 | $128 |
| ADMA Biomanufacturing LLC | 6 | $114 |
| Circassia Inc. | 1 | $98 |
| Phadia US Inc. | 2 | $90 |
| Alk-abello, Inc | 5 | $83 |
| Biocryst US Sales Co., LLC | 3 | $72 |
| Boston Scientific | 1 | $69 |
| Azurity Pharmaceuticals, Inc. | 2 | $50 |
| Aytu Biopharma, Inc. | 3 | $48 |
| Covis Pharma GmbH | 3 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Octapharma USA, Inc. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| GC Biopharma USA, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
How this compares
$10,312 in reported general payments places this provider in the 60th percentile of 140 allergy & immunology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Charlotte
- Maeve OconnorCharlotte$2.2M
- Roopen PatelCharlotte$391K
- John NorrisCharlotte$198K
- Jennifer CaicedoCharlotte$174K
- Vandana PatelCharlotte$105K
- Richard CollinsCharlotte$28K
- Shannon ChadhaCharlotte$22K
- Emily LangleyCharlotte$21K
- Bailee GilchristCharlotte$20K
- Susan HungnessCharlotte$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.